T D Heiman Patterson

Summary

Affiliation: Drexel University
Country: USA

Publications

  1. ncbi request reprint Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS
    T D Heiman-Patterson
    Department of Neurology, Drexel University College of Medicine, Mail Stop 423, 245 North 15th Street, Philadelphia, PA 19102, USA
    J Neurol Sci 236:1-7. 2005
  2. ncbi request reprint Elevated cortical extracellular fluid glutamate in transgenic mice expressing human mutant (G93A) Cu/Zn superoxide dismutase
    G M Alexander
    Department of Neurology, MCP Hahnemann University, Philadelphia, Pennsylvania 19102 1192, USA
    J Neurochem 74:1666-73. 2000
  3. ncbi request reprint The ALSSQOL: balancing physical and nonphysical factors in assessing quality of life in ALS
    Z Simmons
    Department of Neurology, Penn State College of Medicine, Hershey, PA 17033, USA
    Neurology 67:1659-64. 2006
  4. ncbi request reprint A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis
    M E Cudkowicz
    Neurology Clinical Trials Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Neurology 61:456-64. 2003

Collaborators

Detail Information

Publications4

  1. ncbi request reprint Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS
    T D Heiman-Patterson
    Department of Neurology, Drexel University College of Medicine, Mail Stop 423, 245 North 15th Street, Philadelphia, PA 19102, USA
    J Neurol Sci 236:1-7. 2005
    ..This is the first report of a shortened lifespan when the G93A SOD1 transgene is placed on the SJL/J background and an increased survival with the loss of gender influences when the transgene is placed on the C57BL/6J background...
  2. ncbi request reprint Elevated cortical extracellular fluid glutamate in transgenic mice expressing human mutant (G93A) Cu/Zn superoxide dismutase
    G M Alexander
    Department of Neurology, MCP Hahnemann University, Philadelphia, Pennsylvania 19102 1192, USA
    J Neurochem 74:1666-73. 2000
    ....
  3. ncbi request reprint The ALSSQOL: balancing physical and nonphysical factors in assessing quality of life in ALS
    Z Simmons
    Department of Neurology, Penn State College of Medicine, Hershey, PA 17033, USA
    Neurology 67:1659-64. 2006
    ..Current instruments are either too heavily weighted toward strength and physical function or useful for the evaluation of individuals but of less utility in assessing large samples...
  4. ncbi request reprint A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis
    M E Cudkowicz
    Neurology Clinical Trials Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Neurology 61:456-64. 2003
    ..To determine if long-term topiramate therapy is safe and slows disease progression in patients with ALS...